Gilmore O’Neill

Gilmore O’Neill

Chief Executive Officer at EDITAS MEDICINE, INC.

Net worth: 2 M $ as of 30/03/2024

59 year
Health Technology
Consumer Services
Commercial Services

Profile

Gilmore O’Neill occupies the position of Chief Medical Officer & Executive Vice President at Sarepta Therapeutics, Inc. Dr. O’Neill is also on the board of Massachusetts Biotechnology Council and Unity Biotechnology, Inc. and Member of American Academy of Neurology. In his past career he held the position of Senior Vice President for Biogen, Inc. Gilmore O’Neill received an undergraduate degree from University College Dublin and a graduate degree from Harvard University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/03/2024 327,470 ( 0.40% ) 2 M $ 30/03/2024
22/06/2023 0 ( -.--% ) - $ 30/03/2024

Gilmore O’Neill active positions

CompaniesPositionStart
UNITY BIOTECHNOLOGY, INC. Director/Board Member 13/12/2020
EDITAS MEDICINE, INC. Chief Executive Officer 31/05/2022
Corporate Officer/Principal -
Director/Board Member -
All active positions of Gilmore O’Neill

Former positions of Gilmore O’Neill

CompaniesPositionEnd
APTINYX Director/Board Member 13/04/2023
SAREPTA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 16/11/2021
BIOGEN INC. Chief Tech/Sci/R&D Officer 31/05/2018
See the detail of Gilmore O’Neill's experience

Training of Gilmore O’Neill

Harvard University Graduate Degree
University College Dublin Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gilmore O’Neill's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
BIOGEN INC.

Health Technology

SAREPTA THERAPEUTICS, INC.

Health Technology

EDITAS MEDICINE, INC.

Health Technology

APTINYX

Health Technology

UNITY BIOTECHNOLOGY, INC.

Health Technology

Private companies2

Commercial Services

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Gilmore O’Neill